STI and AIMS-AMP Capital Industrial REIT.

STI's movement today shows indecision as it started the day higher, see-sawed a bit and closed almost unchanged at 2839.54. What we can say for sure is that the 50dMA at 2810 provides initial support and the rising 100dMA at 2780 provides a stronger support. It remains to be seen if it could overcome the gap resistance at 2850. If it overcomes 2850, it is good news for the bulls.


I know many out there are turning cautious and even bearish but the higher lows and the higher highs on the MFI are encouraging. We see that in the OBV as well. Failing to move higher, the STI should not come crashing down either. Please see my earlier post on how the STI might behave in March: STI: Marching in place in March.

Turning defensive, I bought more units in AIMS-AMP Capital Industrial REIT today at 21c. Fundamentally, I like the numbers. Please see:AIMS-AMP Capital Industrial REIT. This is probably the best value for money industrial property REIT in Singapore right now. Increasing the weightage of this REIT in my portfolio diversifies away from an emphasis I've had on Saizen REIT in recent months.
Technically, the price looks like it has bottomed at 20.5c and has begun to move up. The MACD did a bullish crossover with the signal line and the stochastics has started to move up from the oversold region. 21.5c is the resistance provided by the flat 50dMA. It might take a while for the counter to move up in price but the limited downside makes it technically attractive to increase my investment here.

Golden Agriculture: Buy signal confirmed.

Crude palm oil (CPO) closed up 1.46% today or RM39 to close at RM2,709 (US$811).  The outlook is bullish and CPO's price might push higher yet.  As mentioned in my previous post on Golden Agriculture, this is good news indeed for the company.

Golden Agriculture did a bullish gap up today, closing at 56c, forming a white spinning top.  Indecision?  Seeing how the spinning top did not take place after at least several consecutive days of upmove in price (because at least several days in one direction is required to qualify price movement as a trend), it is unlikely to be a trend reversal signal. 

The buy signal seen in the MACD is confirmed today.  50% on the MFI has lived up to expectations and acted as a support, preventing the index from declining which would have signalled negative buying momentum.  All in all, chances of Golden Agriculture's price pushing higher seems good.  In the event that 57c is taken out, 59c (138.2% Fibo resistance) would be the resistance to watch. Support remains at 50c, a many times tested candlestick support and resistance level which coincides with the rising 100dMA.

Healthway Medical: A boost from DMG & Partners.

Healthway Medical's target price was revised upwards by DMG & Partners to 26c from 21c after being reduced from 28c not too long ago.  Target price is raised this time "taking into account the potential growth that the new clinics can generate, despite an enlarged share base."  Why didn't they take this into account the last time when the target price was reduced to 21c (the reason given for the lower target price being the dilution from an enlarged share base then)?  It went on to say that "Healthway can potentially open another 30 medical centres in China....This would fuel earnings growth going forward."

Let's look at the charts today.  Price moved to touch a high of 18c after breaking a stubborn resistance level at 17c, forming a white spinning top in the process.  Spinning tops usually signify indecision and are generally treated by chartists as possible reversal signals.  The MFI has moved into overbought territory while 18c happens to be the 138.2% Fibo resistance as well.  However, the expansion in volume today, as price pushed upwards, is impressive and is more than three times the volume of the last session.  This suggests that the price might push higher yet.  If this happens, the XR high of 18.5c will be tested next.

I have sold a third of my remaining position in Healthway Medical today at 17.5c which I've identified as the XR equivalent of 19.5c CR.  This is also fundamentally trading at 10% higher than the fair value I've ascribed to Healthway Medical's shares, which is 16c.  I will sell more if its price moves to retest 18.5c.  Beyond 18.5c, the ultimate bullish target I have is 21.5c which is the XR equivalent of 24c CR I arrived at a couple of months ago.  At 21.5c, I would divest almost all of my investment in the company.  I would have hit my targetted investment returns then.

I maintain that buying into Healthway Medical at prices higher than 16c now is a bet on a very strong improvement in future earnings, strong enough to recover all the EPS lost in dilution and more.  It has to be more or else, Healthway Medical's fair value would stagnate.  I would prefer to be cautious in the midst of too many potentials, especially when mostly positive potentials have been emphasised.

Related post:
Healthway Medical: An updated valuation.